Microvision, Inc. (MVIS) · Oct 28, 2026 · Earnings

MicroVision earnings beat on revenue, but cash burn stays heavy

Beat — Revenue $2.4M vs approximately $2.0M consensus

MicroVision earnings beat revenue expectations and delivered 50% gross margin, but operating losses and cash burn remain substantial despite reaffirmed guidance.

MicroVision is moving from an R&D-heavy lidar developer toward a commercial sensor platform, using the Luminar asset acquisition, IRIS demand, and the MOVIA Pro production launch to convert its backlog into shipped revenue. The prior commercial-growth narrative and $10M–$15M 2026 revenue outlook had already been public, so this quarter mainly tests whether that transition is showing up in the numbers.

MetricQ3 2026Comparison / expectation
Revenue$2.4M$0.2M Q3 2025; approximately $2.0M consensus
Gross margin50%Negative in Q3 2025
Operating expenses$22.5M$12.0M Q3 2025; $24.4M first-half quarterly average
Net loss$12.2M / $0.45 per share$14.2M / $0.72 per share in Q3 2025
Adjusted EBITDA loss$11.1M$11.7M Q3 2025
Cash and cash equivalents$28.9M$32.4M at December 31, 2025
Cash used in operations$13.6MQ3 cash outflow
2026 revenue outlook$10M–$15MReaffirmed

The commercial ramp is real, and revenue narrowly beats the external bar. Quarterly revenue rose to $2.4 million from $0.2 million a year earlier, versus published estimates near $2 million, making this a genuine revenue beat rather than just favorable year-over-year optics. The company also produced a 50% gross margin after a negative prior-year margin. 〔0〕 〔1〕

But the business is still far from self-funding. Operating expenses climbed to $22.5 million, largely because of Luminar, while the quarter consumed $13.6 million of operating cash despite including a $6.3 million German R&D grant. Cash and equivalents ended at $28.9 million, down from $32.4 million at year-end. That leaves the commercial ramp doing the work before the balance sheet does: with $4.8 million of revenue through nine months, MicroVision needs roughly $5.2 million to $10.2 million in Q4 revenue to reach its reaffirmed full-year range. 〔2〕 〔3〕

Cost control improved, but not enough to change the profitability story yet. Quarterly operating expense was about 7.5% below the first-half average, and adjusted EBITDA loss improved modestly year over year. However, the company still posted a $21.3 million operating loss, while weighted-average shares increased to 27.4 million from 19.7 million a year earlier. The lower per-share loss therefore reflects both improved results and a larger share base, not operating profitability. The company’s stated 2027 cash-burn target of $40 million is directionally important, but it remains forward-looking rather than demonstrated in this quarter.

The guidance message is more confirmation than surprise. MicroVision had already reaffirmed the $10 million–$15 million 2026 revenue range earlier in October, so keeping it unchanged is not a fresh upside signal. The new information is that Q3 revenue cleared the modest consensus bar and margins turned positive, while the company still needs a very large Q4 contribution to deliver even the bottom of its range.

Bottom line: This is a narrow earnings beat that validates the first commercial signs of the Luminar-and-MOVIA strategy, especially on revenue and gross margin. It matters, but the heavy cash burn and large Q4 revenue requirement mean the transition is progressing—not yet financially secure.

What to watch next

Q4 results and 2026 revenue closeout, early 2027

Original filing on SEC EDGAR

More Microvision, Inc. news

MicroVision earnings beat on revenue, but cash burn stays heavy | MVIS Stock News
AllSight

Breaking down Wall Street's
information edge.

A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.

—
8-K events this week
—
filings analyzed in total
live · updated 30s ago
Live events · whole market · · --:--:-- ET
AllSight read
Straight from the 8-K
Verbatim from the filing AllSight decoded — highlighted above. Open on SEC EDGAR ↗
Limited-time offerFree 14-day Pro trial
AllSight

Sign in to AllSight

  • Follow any company — we email you the moment it files, free!
  • Your watchlist saved to your account, on every device — free!

by Signing in NOW, claim your FREE 14-day Pro trial!

No password. We email you a 6-digit code. By continuing you agree to our Terms & Privacy.
AllSight · Live plain-English 8-K decodes across the whole US market · Not investment advice.